Denmark has said it would buy 280,000 doses of Novavax's potential Covid-19 vaccine for a total price of 37 million Danish crowns ($5.84m) or roughly $20.9 per dose as part of a European Union agreement with the US company, Reuters reports.
The European Commission said earlier this month it had approved a supply contract with Novavax to buy up to 200m doses of its Covid-19 vaccine candidate, which is yet to be approved by the EU's drugs regulator.
The move to buy Novavax doses is part of the EU's strategy to diversify its vaccine portfolio after the bloc bet heavily on messenger RNA (mRNA) shots produced by Pfizer-BioNTech.
